Teva Board Members Take 50% Pay Cut Post author:Sam Post published:January 10, 2018 Post category:BioPharma Teva has made a target of cutting costs by $3B by the end of 2019. Source: BioSpace You Might Also Like Novartis' New Year Continues With Second FDA Breakthrough Tag of the Week January 3, 2018 Masimo Announces CE Marking Of Rad-97 Pulse CO-Oximeter And Connectivity Hub With Noninvasive Blood Pressure March 19, 2017 Mylan Teams Up with Revance Therapeutics to Develop Botox Biosimilar February 28, 2018
Masimo Announces CE Marking Of Rad-97 Pulse CO-Oximeter And Connectivity Hub With Noninvasive Blood Pressure March 19, 2017
